Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



LAPORTE KATHLEEN Create: Alert

All | News | Filings
Date FiledTypeDescription
02/02/2012 4/A LAPORTE KATHLEEN (Director) has filed a Form 4 on Transcept Pharmaceuticals Inc
Txns: Granted 7,000 options to buy @ $8.18, valued at $57.3k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy